Inhibikase Therapeutics Inc (IKT)

2.30 ↑0.01 (0.44%)
As of March 27, 2024, 3:41pm EST.

IKT Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $0.81 - $4.32
  • Market Capitalization: $14.29M
  • Short Percentage: 0%
  • Target Price: $17.50
  • Shares Outstanding: 6.19M
  • Next Earnings: Nov 30
View More Stats

Catalysts

DateCategoryCatalyst
Help your fellow traders

Stock Details

  • Current Price: $2.30
  • 52-Week Low: $0.81
  • 52-Week High: $4.32
  • Most Recent Quarter: 2023-09-30
  • Shares Float: 5.27M
  • Shares Outstanding: 6.19M
  • Market Capitalization: $14.29M
  • Next Earnings Date: 0000-00-00

Short Interest

  • Shares Short
    (Today):
    0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):
    0
  • Short Interest: 0.00%

The short interest for Inhibikase Therapeutics Inc is at 0.00%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 70.51%
Insiders: 19.21%
Instutitions: 10.28%

Analyst Target Price

17.50

Inhibikase Therapeutics Inc is currently $15.21 below Wallstreet Analysts' price target.

Yesterday's Volume

14,674

Interest in Inhibikase Therapeutics Inc has been trending down. The average daily volume in the past 14 days is 45,488.

Discussions

Please log in or register to share your thoughts.

BritneyHuphrey

$IKT breaking out of this wedge sooner than later

0 Like Report
graffititrain

$IKT breaking out of this wedge sooner than later

0 Like Report